Research Article
Liu Wei Di Huang Wan and the Delay of Insulin Use in Patients with Type 2 Diabetes in Taiwan: A Nationwide Study
Table 2
Types of antidiabetic drug.
| | Drug type | ACT code | Drug name |
| | Biguanides | A10BA | Metformin HCL | | Buformin HCL |
| | Sulfonylureas | A10BB | Glyburide | | Chlorpropamide | | Tolbutamide | | Glibornuride | | Tolazamide | | Glipizide | | Gliquidone | | Gliclazide | | Glimepiride | | Acetohexamide |
| | Combinations of oral blood glucose-lowering drugs | A10BD | Metformin and glimepiride | | Metformin and repaglinide | | Metformin and sulfonylureas | | Metformin and rosiglitazone | | Metformin and pioglitazone | | Metformin and sitagliptin | | Metformin and vildagliptin | | Metformin and saxagliptin | | Metformin and linagliptin |
| | Alpha-glucosidase inhibitors | A10BF | Acarbose | | Miglitol |
| | Thiazolidinediones | A10BG | Rosiglitazone | | Pioglitazone |
| | Dipeptidyl peptidase 4 (DPP-4) inhibitors | A10BH | Sitagliptin | | Vildagliptin | | Saxagliptin | | Linagliptin |
| | Other blood glucose-lowering drugs, excl. insulins | A10BX | Guar gum | | Repaglinide | | Nateglinide | | Exenatide | | Liraglutide | | Mitiglinide calcium hydrate |
|
|
